From the Journals

ECPR Shows Promise in Cardiac Arrest

Timing, patient selection, and system factors continue to shape its role

Share

Extracorporeal cardiopulmonary resuscitation (ECPR) using veno-arterial extracorporeal membrane oxygenation may enhance survival rates in out-of-hospital cardiac arrest (OHCA) patients, though randomized trials show mixed results. Despite advances, survival rates remain low, around 9% to 14%. While early studies suggest benefits, key trials like ARREST and INCEPTION produced inconsistent outcomes due to patient selection and logistical challenges. Optimal results appear limited to experienced centers. Ongoing research aims to clarify ECPR's role and improve patient outcomes.

Original Source(s)

ECPR Shows Promise in Cardiac Arrest

  • by Olivia Anderson

  • March 19, 2026

Related Content

Statins and Survival After 80

Cohort analysis associates primary prevention with lower mortality and coronary morbidity

PREVENT Equations Show How Age, Risk Factors Shape CVD Risk

Systematic analysis demonstrates how kidney disease, diabetes, and other factors accelerate 10-year cardiovascular risk, helping guide clinician–patient prevention discussions.

Premature Menopause Tied to Higher Lifetime CHD Risk

Lifetime risk estimates evaluated by menopause timing.